Tag «AstraZeneca»

AstraZeneca strengthens innovation partnerships with NASSCOM – CoE IoT and Unnati to address Non-Communicable Diseases (NCDs) in India

Leif Johansson, Non-Executive Chairman of the Board, AstraZeneca PLC visits India to expand AstraZeneca’s commitment to healthcare and innovation in India AstraZeneca announces finalists of the Unnati Healthcare Innovation Challenge and joins hands with NASSCOM on healthcare accelerator programme New Delhi, February 21, 2019: Leif Johansson, Chairman of the Board, AstraZeneca Plc during his three …

New Data Shows ZINFORO™ is More Effective Compared to Ceftriaxone in Adult Patients With Community Acquired Pneumonia in the Asian Region

BARCELONA, Spain, May 12, 2014 /PRNewswire/ — Phase III Data presented at 24th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) AstraZeneca has announced results from a Phase III comparator trial, which demonstrated ZINFORO™ (ceftaroline fosamil) 600mg twice daily is more effective compared to ceftriaxone 2g for treating Asian patients with community-acquired pneumonia (CAP). Results …